Oruka Therapeutics Inc. (ORKA)
NASDAQ: ORKA
· Real-Time Price · USD
14.65
0.09 (0.62%)
At close: Aug 20, 2025, 12:51 PM
Oruka Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -99.98M | -78.08M | -64.16M | -38.38M | -9.76M | -7.08M | -18.49M | -19.32M | -18.77M | -16.05M | -12.52M |
Depreciation & Amortization | 51K | 44K | 28K | 12K | 12K | n/a | 102K | 91K | 79K | 78K | 85K |
Stock-Based Compensation | 5.08M | n/a | 85K | 85K | 85K | 85K | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 2.24M | 4.87M | 8.98M | 6.84M | 907K | 987K | 602K | 383K | 873K | -132K | -449K |
Other Non-Cash Items | -8.84M | -7.35M | -10.5M | -13.46M | 113K | 1K | 525K | 497K | 396K | 297K | 168K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 6M | 8.21M | 18.07M | 14.09M | 6.74M | 6.82M | 32K | -28K | 1.49M | 1.73M | 1M |
Operating Cash Flow | -97.69M | -77.18M | -56.48M | -37.66M | -2.8M | -168K | -17.84M | -18.76M | -16.81M | -13.94M | -11.26M |
Capital Expenditures | -236K | -202K | -189K | -171K | n/a | n/a | -39K | -43K | -49K | -35K | -22K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -152.29M | -44.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 200.06M | 87.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -329.94M | -329.94M | -329.94M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -282.4M | -287.26M | -330.13M | -171K | n/a | n/a | -39K | -43K | -49K | -35K | -22K |
Debt Repayment | n/a | n/a | 24.98M | 24.98M | 24.98M | 24.98M | n/a | n/a | -137K | -273K | -408K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 29.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 449.63M | 449.54M | 477.45M | 477.98M | 27.93M | 27.91M | n/a | 23.09M | 24.08M | 66.13M | 71.55M |
Net Cash Flow | 32.11M | 47.67M | 53.41M | 402.71M | 25.12M | 27.74M | -17.87M | 4.29M | 7.22M | 52.16M | 60.26M |
Free Cash Flow | -97.92M | -77.38M | -56.67M | -37.83M | -2.8M | -168K | -17.87M | -18.8M | -16.86M | -13.98M | -11.29M |